Acasă › Cancer de sân › California › Santa Monica
Studii clinice pentru Cancer de sân în Santa Monica, CA
28 studii pentru Cancer de sân caută participanți în și în jurul orașului Santa Monica (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
În curs de recrutareFaza 3
- Beverly Hills Cancer Center, Beverly Hills · La 6 mi distanță
A Study of PHST001 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Precision NextGen Oncology & Research Center, Beverly Hills · La 6 mi distanță
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
În curs de recrutareFaza 2
- Beverly Hills Cancer Center, Beverly Hills · La 6 mi distanță
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
În curs de recrutareFaza 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
În curs de recrutare
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
În curs de recrutareFaza 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · La 6 mi distanță
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
În curs de recrutareFaza 3
- Clinical Trial Site, Beverly Hills · La 6 mi distanță
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
În curs de recrutareFaza 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
În curs de recrutareFaza 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
În curs de recrutareFaza 1/2
- Beverly Hills Cancer Center, Beverly Hills · La 6 mi distanță
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
În curs de recrutareFaza 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · La 6 mi distanță
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
În curs de recrutareFaza 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
În curs de recrutareFaza 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
În curs de recrutareFaza 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- și încă 1
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- Tower Cancer Research Foundation, Beverly Hills · La 6 mi distanță
- Cedars-Sinai Cancer - Tarzana, Tarzana · La 11 mi distanță
- Kaiser Permanente-Woodland Hills, Woodland Hills · La 12 mi distanță
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
În curs de recrutareFaza 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · La 6 mi distanță
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
În curs de recrutareFaza 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · La 11 mi distanță
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
În curs de recrutareFaza 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
În curs de recrutareFaza 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · La 12 mi distanță
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
În curs de recrutareFaza 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · La 4 mi distanță
- Precision NextGen Oncology & Research Center, Beverly Hills · La 6 mi distanță
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
În curs de recrutareFaza 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · La 11 mi distanță
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
În curs de recrutareStudiu observațional
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Durham, NC64 studii
- Chicago, IL59 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
Alte studii în Santa Monica
- Cancer pulmonar cu celule non-pătrate45 studii
- Cancer colorectal23 studii
- Cancer (toate tipurile)22 studii
- Cancer metastatic19 studii
- Cancer pulmonar15 studii
- Cancer ovarian15 studii
- Cancer de prostată15 studii
- Carcinom cu celule scuamoase de cap și gât13 studii
- Insuficiență cardiacă11 studii
- Cancer endometrial10 studii
- Cancer gastric9 studii
- Cancer pancreatic9 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.